EGM
IBB icon

Encore Global Management’s iShares Biotechnology ETF IBB Stock Holding History

Encore Global Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,000
Closed -$1.01M – 56
2026
Q1 		$1.01M Buy
+6,000
New +$1.03M 0.71% 54

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Encore Global Management's IBB Position: Q2 2026 in Review

Encore Global Management sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 6,000 shares — an estimated $1.01M sold.

Encore Global Management first reported a position in IBB in Q1 2026 and held it in 1 quarter. The position peaked at $1.01M in Q1 2026. 955 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Encore Global Management reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • Encore Global Management sold 6,000 iShares Biotechnology ETF shares in Q2 2026, an estimated $1.01M.
  • Encore Global Management first reported a position in iShares Biotechnology ETF in Q1 2026 and held it in 1 quarter.
  • Encore Global Management's iShares Biotechnology ETF position peaked at $1.01M in Q1 2026.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Encore Global Management's 13F filing for Q2 2026, filed 11 Aug 2026.